| 751008 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Kidney injury in COVID-19 patients, drug development and their renal complications: Review study |
2021-10-01 |
10.1016/j.biopha.2021.111966 |
Mohamadi Yarijani Zeynab, Najafi Houshang |
| 751007 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
In silico drug repurposing in COVID-19: A network-based analysis |
2021-10-01 |
10.1016/j.biopha.2021.111954 |
Sibilio Pasquale, Bini Simone, Fiscon Giulia, Sponziello Marialuisa, Conte Federica, Pecce Valeria, Durante Cosimo, Paci Paola, Falcone Rosa, Norata Giuseppe Danilo, Farina Lorenzo, Verrienti Antonella |
| 751006 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients |
2021-10-01 |
10.1016/j.biopha.2021.112067 |
D`Avila-Mesquita Carolina, Couto Ariel E.S., Campos Ligia C.B., Vasconcelos Tauana F., Michelon-Barbosa Jessyca, Corsi Carlos A.C., Mestriner Fabiola, Petroski-Moraes Bruno C., Garbellini-Diab Maria J., Couto Daniel M.S., Jordani Maria C., Ferro Denise, Sbragia Lourenço, Joviliano Edwaldo E., Evora Paulo R., Carvalho Santana Rodrigo de, Martins-Filho Olindo Assis, Polonis Katarzyna, Menegueti Mayra G., Ribeiro Mauricio S., Auxiliadora-Martins Maria, Becari Christiane |
| 751005 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations |
2021-10-01 |
10.1016/j.biopha.2021.112023 |
Dabholkar Neha, Gorantla Srividya, Dubey Sunil Kumar, Alexander Amit, Taliyan Rajeev, Singhvi Gautam |
| 751004 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2 |
2021-10-01 |
10.1016/j.biopha.2021.112011 |
Tsai Ming-Shao, Yang Yao-Hsu, Lin Yu-Shih, Chang Geng-He, Hsu Cheng-Ming, Yeh Reming-Albert, Shu Li-Hsin, Cheng Yu-Ching, Liu Hung-Te, Wu Yu-Huei, Wu Yu-Heng, Shen Rou-Chen, Wu Ching-Yuan |
| 751003 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 |
2021-10-01 |
10.1016/j.biopha.2021.111980 |
Maione Francesco, Casillo Gian Marco, Raucci Federica, Salvatore Cristian, Ambrosini Giovanna, Costa Luisa, Scarpa Raffaele, Caso Francesco, Bucci Mariarosaria |
| 751002 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status |
2021-10-01 |
10.1016/j.biopha.2021.111956 |
Chowdhury Apu, Sajid Muhammad, Jahan Nabila, Adelusi Temitope Isaac, Maitra Pulak, Yin Guolian, Wu Xudong, Gao Yuan, Wang Sicen |
| 751001 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2 |
2021-10-01 |
10.1016/j.biopha.2021.111953 |
Granados-Riveron Javier T., Aquino-Jarquin Guillermo |
| 751000 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Retraction notice to “Inhibition of miR-31a-5p decreases inflammation by down-regulating IL-25 expression in human dermal fibroblast cells (CC-2511 cells) under hyperthermic stress via Wnt/β-catenin pathway” [Biomed. Pharmacother. 107 (2018) 24–33] |
2021-10-01 |
10.1016/j.biopha.2021.112129 |
Jiang Lei, Xue Wenjun, Wang Yibing |
| 750999 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Retraction notice to “Long noncoding RNA maternally expressed gene 3 knockdown alleviates lipopolysaccharide induced inflammatory injury by up-regulation of miR-203 in ATDC5 cells” [Biomed. Pharmacother. 100 (2018) 240–249] |
2021-10-01 |
10.1016/j.biopha.2021.112099 |
Wang Zhaolin, Chi Xiaohua, Liu Liping, Wang Yaqun, Mei Xiaoyan, Yang Yan, Jia Tanghong |
